Abstract:The MIR663AHG gene encodes both miR663AHG and miR663a. While miR663a contributes to the defense of host cells against inflammation and inhibits colon cancer development, the biological function of lncRNA miR663AHG has not been previously reported. In this study, the subcellular localization of lncRNA miR663AHG was determined by RNA-FISH. miR663AHG and miR663a were measured by qRT-PCR. The effects of miR663AHG on the growth and metastasis of colon cancer cells were investigated in vitro and in vivo. CRISPR/Cas9, RNA pulldown, and other biological assays were used to explore the underlying mechanism of miR663AHG. We found that miR663AHG was mainly distributed in the nucleus of Caco2 and HCT116 cells and the cytoplasm of SW480 cells. The expression level of miR663AHG was positively correlated with the level of miR663a (r = 0.179, P = 0.015) and significantly downregulated in colon cancer tissues relative to paired normal tissues from 119 patients (P < 0.008). Colon cancers with low miR663AHG expression were associated with advanced pTNM stage (P = 0.021), lymph metastasis (P = 0.041), and shorter overall survival (hazard ratio = 2.026; P = 0.021). Experimentally, miR663AHG inhibited colon cancer cell proliferation, migration, and invasion. The growth of xenografts from RKO cells overexpressing miR663AHG was slower than that of xenografts from vector control cells in BALB/c nude mice (P = 0.007). Interestingly, either RNA-interfering or resveratrol-inducing expression changes of miR663AHG or miR663a can trigger negative feedback regulation of transcription of the MIR663AHG gene. Mechanistically, miR663AHG could bind to miR663a and its precursor pre-miR663a, and prevent the degradation of miR663a target mRNAs. Disruption of the negative feedback by knockout of the MIR663AHG promoter, exon-1, and pri-miR663A-coding sequence entirely blocked these effects of miR663AHG, which was restored in cells transfected with miR663a expression vector in rescue experiment. In conclusion, miR663AHG functions as a tumor suppressor that inhibits the development of colon cancer through its cis-binding to miR663a/pre-miR663a. The cross talk between miR663AHG and miR663a expression may play dominant roles in maintaining the functions of miR663AHG in colon cancer development.

miR663a‑TTC22V1 axis inhibits colon cancer metastasis.

MicroRNA-206 Attenuates Tumor Proliferation and Migration Involving the Downregulation of NOTCH3 in Colorectal Cancer.

Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells.

LncRNA Mir663ahg Represses the Development of Colon Cancer in a Mir663a-Dependent Manner

Mir-106B-5p Inhibits the Invasion and Metastasis of Colorectal Cancer by Targeting CTSA

MicroRNA-638 Inhibits Cell Proliferation, Invasion and Regulates Cell Cycle by Targeting Tetraspanin 1 in Human Colorectal Carcinoma.

MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer

MicroRNA-663 Suppresses the Proliferation and Invasion of Colorectal Cancer Cells by Directly Targeting FSCN1

MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro.

MicroRNA-302c Represses Epithelial-Mesenchymal Transition and Metastasis by Targeting Transcription Factor AP-4 in Colorectal Cancer.

miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt/β-catenin signaling pathway

Mir-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A.

MALAT1–miR663a Negative Feedback Loop in Colon Cancer Cell Functions Through Direct Mirna–lncrna Binding

Biology of Human Tumors miR-2045 p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB 22 A

Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma.

MicroRNA-363-3p inhibits colorectal cancer progression by targeting interferon-induced transmembrane protein 1

MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition

MicroRNA-106a Promotes Cell Migration and Invasion by Targeting Tissue Inhibitor of Matrix Metalloproteinase 2 in Cervical Cancer

MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells

Mir-338-3p Suppresses Colorectal Cancer Proliferation and Progression by Inhibiting MACC1.

Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2